Web Analytics
หุ้น TXG (NASDAQ) | 10X GENOMICS INC – วิเคราะห์โดย Deepscope
MARKET

Select Market Data Region

TXG — 10X GENOMICS INC (Healthcare >> Health Information Services)

TXG FAQ

What is TXG's P/E ratio?

10X GENOMICS INC (TXG) currently trades at a P/E ratio of 123.14.

What is TXG's ROE?

10X GENOMICS INC reports a Return on Equity (ROE) of -2.78%.

What is TXG's dividend yield?

10X GENOMICS INC offers a dividend yield of 0.00%.

What is TXG's Deepscope Quality Score?

Deepscope rates TXG's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy TXG?

Deepscope's AI Timing Score for TXG is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does TXG belong to?

10X GENOMICS INC is classified under the Healthcare >> Health Information Services sector on the NASDAQ exchange.

Stock Check   *ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.*
(Price: 2026-06-05 | FS: 2026-03-31)

TXG

10X GENOMICS INC
USD 31.04
-2.46 (-7.34%) Day Change
123.14
P/E
0.01
D/E
-2.8%
ROE
-2.2%
ROA
0.00%
Div Yield
-6.37
PEG
USD 31.04
Price
-2.46 (-7.34%)
Day Change
NEWS SCORE: 99

TXG มีคุณภาพโดยรวมไม่ดี ( คะแนนปัจจัยพื้นฐาน = 31) แต่ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
P/E ratio ค่อนข้างสูง
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตราผลตอบแทนผู้ถือหุ้น (ROE) ต่ำกว่าเกณฑ์
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำเมื่อเทียบกับอัตราผลตอบแทนผู้ถือหุ้น(ROE)
อัตราเร่งของการเติบโตของอัตราผลตอบแทนสินทรัพย์ (ROA) ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร ยังไม่ดีนัก , ...

ปัจจัยทางคุณภาพ 39%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 31.04
  PBV / Sector
5.22 / 4.52
  Earning Per Share -0.17
  PE / Sector
123.14 / 45.70
  PEG or PE/Growth / Sector
-6.37 / -0.26
  Average 1M Daily Value
77.27 M
  Average 1W Daily Value
106.29 M
GREAT
ปัจจัยทางเทคนิค 57%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
สุขภาพทางการเงิน 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ประสิทธิภาพการทำกำไร 52%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-3.55 / 25.29
  NPM Average (%) / Sector
-22.72 / -3.82
  NPM Change Average (%) / Sector
-31.05 / -61.77
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-2.23 / 8.28
  ROA Average (%) / Sector
-13.77 / -0.58
  ROA Change Average (%) / Sector
-21.64 / -64.42
  ROE (%) / Sector
-2.78 / 16.35
  ROE Average (%) / Sector
-17.80 / 0.86
  ROE Change Average (%) / Sector
-21.51 / -69.53
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
ผลตอบแทนต่อผู้ถือหุ้น 4%
X
  Dividend (%) / Sector
N/A / 0.88
  Dividend Average (%) / Sector
N/A / 5.13
  Dividend Change Average (%) / Sector
N/A / 3.06
รายละเอียดการจดทะเบียน
X
  Analyze Date 2026-06-06 09:08:30
  Symbol TXG
  Name 10X GENOMICS INC
  Sector Healthcare >> Health Information Services
  Market NASDAQ
  Listed Shares 116.88 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 4,253.03 / 3,839.73
ข่าว, ประมาณการ, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260

Phone: 925 401 7300

Website: https://www.10xgenomics.com

Employees: 1,178

Sector: Healthcare >> Health Information Services

Description: 10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

ME vs SECTOR Healthcare >> Health Information Services

TXG (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
TXG
TXG
USD 31.04 (-7.34%)
+ Watch + Port Chart